Showing results (901-910 of 1,079) with videos related to

Sort By:
Pageof 108
Bioorganic & Medicinal Chemistry Letters|December 27, 2011
Discovery of dehydro-oxopiperazine acetamides as novel bradykinin B1 receptor antagonists with enhanced in vitro potencyWenyuan Qian, Jian Jeffrey Chen, Jason Human, et al.
Clinical Endocrinology|May 1, 2015
Sympathetic activation and endothelial dysfunction in polycystic ovary syndrome are not explained by either obesity or insulin resistanceElisabeth A Lambert, Helena Teede, Carolina Ika Sari, et al.
Journal of Neuro-Oncology|March 8, 2016
Management patterns of patients with cerebral metastases who underwent multiple stereotactic radiosurgeriesDeborah C Marshall, Logan P Marcus, Teddy E Kim, et al.
Chembiochem : a European Journal of Chemical Biology|June 1, 2022
Luminescent Assay for the Screening of SARS-CoV-2 M<sup>Pro</sup> InhibitorsDaan Sondag, Jona Merx, Emiel Rossing, et al.
JMIR Research Protocols|November 4, 2018
Efficacy of an Online Self-Help Treatment for Comorbid Alcohol Misuse and Emotional Problems in Young Adults: Protocol for a Randomized Controlled TrialJona R Frohlich, Karli K Rapinda, Michael P Schaub, et al.
Bioorganic & Medicinal Chemistry Letters|July 28, 2006
Preparation of 1-(3-aminobenzo[d]isoxazol-5-yl)-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-ones as potent, selective, and efficacious inhibitors of coagulation factor XaYun-Long Li, John M Fevig, Joseph Cacciola, et al.
British Journal of Haematology|August 20, 2008
Serum autotaxin measurement in haematological malignancies: a promising marker for follicular lymphomaAkiko Masuda, Kazuhiro Nakamura, Koji Izutsu, et al.
Nucleic Acids Research|February 23, 2026
HCR-Proxy resolves site-specific proximal RNA microenvironments at subcompartmental resolutionAnja Trupej, Valter Bergant, Jona Novljan, et al.
Breast (Edinburgh, Scotland)|June 18, 2022
A nested case-control study on radiation dose-response for cardiac events in breast cancer patients in GermanyDan Baaken, Hiltrud Merzenich, Marcus Schmidt, et al.
Antimicrobial Agents and Chemotherapy|October 16, 2001
DPC 681 and DPC 684: potent, selective inhibitors of human immunodeficiency virus protease active against clinically relevant mutant variantsR F Kaltenbach, G Trainor, D Getman, et al.
Pageof 108